Immune Globulin (Intravenous) (IGIV): What Is The Most Important Information I Should Know About IGIV?
content provided by Cerner Multum, Inc.
| Pronunciation: | ih MUNE GLAW byoo lin |
| Brand: | Carimune, Gamimune N 10%, Gamimune N 5%, Gammagard S/D, Gammar-P I.V., Iveegam, Panglobulin, Polygam S/D, Sandoglobulin, Venoglobulin-S 10%, Venoglobulin-S 5% |
What is the most important information I should know about IGIV?
IGIV is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although IGIV is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using IGIV.
 |
Treatment with IGIV has been associated with the development of kidney problems, sometimes resulting in kidney failure and/or death. Notify your doctor immediately if you develop decreased urination, sudden weight gain, fluid retention or swelling, or shortness of breath. These may be signs of kidney problems. |
| |
Rare cases of aseptic meningitis syndrome (AMS) have been associated with the use of IGIV. Notify your doctor immediately if you experience severe headache, neck stiffness, drowsiness, fever, eye sensitivity to light, painful eye movements, and nausea or vomiting. These may be signs of AMS. Stopping treatment with IGIV has resulted in resolution of AMS without any lasting problems. |
Print This
| Last updated: | July 8, 2004 |
|---|
© 2007, Cerner Multum, INC. Version: 5.02.
This information is not intended to replace the advice of a doctor. By using AOL Body, you indicate that you have read, understood, and agreed to our Terms of Service, Use of Content Agreement and AOL Body Advertising Policy. Read more about our content partners.
